title: Combination therapy with tamoxifen and amphotericin B in experimental cutaneous leishmaniasis.
abstract: Leishmaniasis chemotherapy remains very challenging. The high cost of active drugs, along with the severity of their side effects and the increasing failure rate of the current therapeutic schemes, calls for the discovery of new active drugs and schemes of treatment. The use of combination therapy has gained much attention in recent years as a possible strategy for overcoming the various shortcomings in the present arsenal. We recently described the effectiveness of tamoxifen in murine models of leishmaniasis, and here, we investigated the interactions between tamoxifen and amphotericin B, one of the most potent drugs used in leishmaniasis treatment. The in vitro interactions were indifferent for the association of tamoxifen and amphotericin B. The association was also assayed in vivo in Leishmania amazonensis-infected BALB/c mice and was found to yield at least additive effects at low doses of both drugs.
authors.affiliation: Departamento de Parasitologia, Instituto de Ciências Biomédicas, Universidade de São Paulo, São Paulo, Brazil.
authors.forename: Cristiana T
authors.initials: CT
authors.lastname: Trinconi
authors.forename: Juliana Q
authors.initials: JQ
authors.lastname: Reimão
authors.forename: Jenicer K U
authors.initials: JK
authors.lastname: Yokoyama-Yasunaka
authors.forename: Danilo C
authors.initials: DC
authors.lastname: Miguel
authors.forename: Silvia R B
authors.initials: SR
authors.lastname: Uliana
mesh_terms: D000666:Amphotericin B / Q000494:pharmacology* / Q000627:therapeutic use*; D000818:Animals; D000981:Antiprotozoal Agents / Q000494:pharmacology* / Q000627:therapeutic use*; D004195:Disease Models, Animal; D005260:Female; D016773:Leishmaniasis, Cutaneous / Q000188:drug therapy; D051379:Mice; D008807:Mice, Inbred BALB C; D013629:Tamoxifen / Q000494:pharmacology* / Q000627:therapeutic use*
chemical_list: D000981:Antiprotozoal Agents; D013629:Tamoxifen; D000666:Amphotericin B